Michael Roden
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Physiology top 0.05%
- Adipose Tissue and Metabolism
- Diet and metabolism studies
Papers in
-
- Diet, Metabolism, and Disease 51
- Diabetes Treatment and Management 42
- Physiology 161
- Adipose Tissue and Metabolism 81
- Diet and metabolism studies 67
- Co-authors
- Gerald I. Shulman (21 shared papers)Christian Herder (177 shared papers)Julia Szendroedi (113 shared papers)P. Nowotny (77 shared papers)W. Waldhäusl (59 shared papers)Douglas L. Rothman (5 shared papers)Martin Krššák (30 shared papers)Tomáš Jeleník (40 shared papers)
- Journals
- Diabetes (58 papers)Diabetologia (51 papers)Diabetes Care (32 papers)The Journal of Clinical Endocrinology & Metabolism (26 papers)PLoS ONE (24 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Michael Roden
665 papers receiving 33.3k citations
Michael Roden's Hit Papers
Peers
Comparison fields: 5 of 180
- Endocrinology, Diabetes and Metabolism 6.9k
- Physiology 9.4k
- Epidemiology 8.4k
- Endocrine and Autonomic Systems 1.2k
- Biochemistry 1.0k
Countries citing papers authored by Michael Roden
This map shows the geographic impact of Michael Roden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Roden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Roden more than expected).
Fields of papers citing papers by Michael Roden
This network shows the impact of papers produced by Michael Roden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Roden. The network helps show where Michael Roden may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Roden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 706 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mechanism of free fatty acid-induced insulin resistance in humans. Hit paper breakdown → | 1996 | 1174 |
| 2 | Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study Hit paper breakdown → | 1999 | 997 |
| 3 | Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions Hit paper breakdown → | 2011 | 839 |
| 4 | The integrative biology of type 2 diabetes Hit paper breakdown → | 2019 | 794 |
| 5 | NAFLD and diabetes mellitus Hit paper breakdown → | 2016 | 767 |
| 6 | Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach Hit paper breakdown → | 2012 | 765 |
| 7 | Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis Hit paper breakdown → | 2015 | 765 |
| 8 | EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) Hit paper breakdown → | 2024 | 756 |
| 9 | The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments Hit paper breakdown → | 2021 | 580 |
| 10 | Increased Glucose Transport–Phosphorylation and Muscle Glycogen Synthesis after Exercise Training in Insulin-Resistant Subjects Hit paper breakdown → | 1996 | 522 |
| 11 | 2011 | 467 | |
| 12 | 2004 | 439 | |
| 13 | Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2013 | 375 |
| 14 | 2007 | 364 | |
| 15 | 2014 | 325 | |
| 16 | 2006 | 323 | |
| 17 | 2002 | 314 | |
| 18 | 2005 | 308 | |
| 19 | 2013 | 280 | |
| 20 | Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis Hit paper breakdown → | 2025 | 271 |
About Michael Roden
Michael Roden is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Epidemiology, Molecular Biology and Surgery, having authored 706 papers that have together received 34.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (110 papers), Adipose Tissue and Metabolism (81 papers), Metabolism, Diabetes, and Cancer (74 papers), Diet and metabolism studies (67 papers), Diet, Metabolism, and Disease (51 papers), Diabetes and associated disorders (45 papers), Adipokines, Inflammation, and Metabolic Diseases (44 papers) and Diabetes Treatment and Management (42 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.9k citations), Physiology (9.4k citations), Epidemiology (8.4k citations), Endocrine and Autonomic Systems (1.2k citations) and Biochemistry (1.0k citations). Michael Roden has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Gerald I. Shulman, Christian Herder, Julia Szendroedi, P. Nowotny, W. Waldhäusl, Douglas L. Rothman, Martin Krššák, Tomáš Jeleník, Gary W. Cline and Michael Krebs. Their work appears in journals such as Diabetes, Diabetologia, Diabetes Care, The Journal of Clinical Endocrinology & Metabolism and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.